Latest in Health & Wellness: Sep 28 (5 stories)
Sunday, 28 Sep 2025 Weekly Health & Wellness GLOBAL
Here is your Weekly summary for Health & Wellness across the world for Mon 22nd September - Sun 28th September 2025
Recent discussions around the fertility industry spotlight Kindbody, a company facing scrutiny for prioritizing sales targets over patient care. Internal documents reveal that doctors are pressured to recommend more expensive IVF procedures, raising ethical concerns about patient welfare in an unregulated market. Meanwhile, Asian pharmaceutical stocks are reacting negatively to new 100% tariffs on branded drugs announced by Trump, which could significantly impact the industry. Additionally, health providers are bracing for a potential $32 billion loss if enhanced ACA subsidies are not extended amid ongoing government funding debates.
Featured Articles
Key stories and insights from this topic
-
Health providers could lose $32 billion if ACA credits at center of shutdown fight expire
US Top News and Analysis 25 Sep 2025, 7:54pmDemocrats demand that any stopgap funding measure to keep the federal government open include an extension of the enhanced Obamacare subsidies credits.
-
IVF Disrupted, The Kindbody Story: The Baby Project
Bloomberg Technology 27 Sep 2025, 2:15pmIn this episode of IVF Disrupted: The Kindbody Story, a billionaire’s “baby project” and what it illustrates about America's unregulated fertility industry.
-
The Kindbody Story: E4, IVF Meets Sales Targets (Podcast)
Bloomberg Technology 26 Sep 2025, 6:00pmKindbody implements quotas requiring doctors to perform more lucrative procedures, internal company documents show. In Episode 4 of IVF Disrupted: The Kindbody Story, patients report being pushed toward expensive IVF cycles and questionable add-ons.
-
17 Best Air Purifiers (2025): Coway, AirDoctor, IQAir
WIRED 26 Sep 2025, 2:07pmProtect your home against dust, pets, allergies, and more with air purifiers tested firsthand by WIRED.
-
Asian pharma stocks extend declines after Trump slaps 100% levies on branded drugs
US Top News and Analysis 26 Sep 2025, 4:39amThe 100% duties apply to "any branded or patented Pharmaceutical Product" except for companies that build manufacturing plants in the U.S., Trump said Friday.
No related topic summaries yet
Check back soon for more content on this topic.